ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2025
Quality of life measures in treatment for active substance misuse: a scoping review.
Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeUnlike previous reviews on quality of life (QoL) and substance use disorders (SUD), this scoping review focuses on QoL within the context of SUD treatment and active substance misuse. This review delineates and describes QoL measures, assesses their application, and explores the influence of demographics on QoL outcomes.
methodsFive databases were searched (EMBASE, Web of Science, PsycINFO, PubMed, and Scopus) using keywords related to QoL, clinician-verified SUD, and SUD treatment. All studies were published in English before June 1st, 2025. Two reviewers screened abstracts and full text for eligibility and study elements. The first author extracted data regarding methodology, substance use, treatment, and QoL measures. The PRISMA-ScR checklist guided this study and the reporting process for rigor and transparency.
resultsOf the 11,078 initially identified articles, 108 were extracted for analysis. QoL measures accounted for multiple domains (e.g., physical, psychological, social, environmental, independence, security, and spiritual). Studies included male and female participants, all over the age of 18. Results found that many studies under-reported race, ethnicity, and cultural contexts, as well as high variability in the definition of QoL domains and standardization across treatment locations and geographic regions. Studies from Asia primarily showed preference for the WHOQOL-BREF measure compared to North America and Europe, which showed varied preference for measures. The most common QoL domains assessed were psychological, physical, and social.
conclusionThis review highlights the need to operationalize QoL domains and assessment approaches in SUD treatment research to facilitate meaningful comparisons and enhance our understanding of treatment effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.